Loading organizations...
§ Private Profile · Buffalo, NY, USA
Develops electronic medical devices for infection-detection and treatment on orthopedic implants, eliminating biofilm.
Based in Buffalo, New York, Garwood Medical Devices develops electronic medical technologies designed to eliminate biofilm infections on orthopedic implants. The company's lead product, BioPrax, utilizes infection-detection and treatment technology originally licensed from the University at Buffalo and Syracuse University, supplemented by additional patents developed internally. This primary device has secured Breakthrough Device designation from the FDA and is currently advancing toward human clinical trials following successful in vitro and in vivo laboratory studies. Operating as a venture-funded enterprise targeting hospitals and specialized orthopedic surgeons, the firm has raised approximately $15 million in total funding to date. This capitalization includes a $2 million Series A round, a $797,000 equity financing tranche in 2022, and a strategic mentorship grant from Johnson & Johnson. The company was founded in 2014 by Brian Peterson, Gregg Gellman, and Wayne Bacon.
Garwood Medical Devices has raised $7.7M across 2 funding rounds.
Garwood Medical Devices has raised $7.7M in total across 2 funding rounds.
Garwood Medical Devices has raised $7.7M in total across 2 funding rounds.
Garwood Medical Devices's investors include The Murray Family, WNY Impact Investment Fund.
Garwood Medical Devices has raised $7.7M across 2 funding rounds. Most recently, it raised $4.0M Series C in August 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 20, 2020 | $4M Series C | The Murray Family | — | Announced |
| Dec 16, 2019 | $3.7M Series B | — | WNY Impact Investment Fund | Announced |